Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Proteoglycan degrading mutants for the treatment of CNS

Proteoglycan degrading mutants for the treatment of CNS

US Patent 7968089 · Granted Jun 28, 2011

Estimated economic value: $7,566,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sustained release compositions of 4-aminopyridine2024
Inflatable grow tent with integrated lighting2023
Compact photobioreactor with built-in lights2022
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or pro2022
Methods of reducing extravasation of inflammatory cells2021
Methods of reducing extravasation of inflammatory cells2021
Methods for detecting cardiac damage2021
Method for achieving desired glial growth factor 2 plasma levels2020
Compositions and methods for treatment during non-acute periods following CNS ne2020
Controlling the degradation of bioresorbable metal implants2020
Method and device for activating stem cells2019
Compositions and methods of using chondroitinase ABCI mutants2019